Summary
The paucity of information on the effect of long-term high-dose salmon calcitonin administration on normal bone mineral metabolism and histology prompted an investigation of the influence of high-dose synthetic calcitonin in the rat. Serum ionized calcium, osteocalcin or BGP (bone gla protein), and immunoreactive PTH were measured serially during calcitonin administration and bone histomorphometry analyzed at 6 weeks (after sacrifice). Daily injections of salmon calcitonin, 0.4 IU/100 g (group B) and 2 IU/100 g (group C), resulted in significant hypocalcemia at 4 hours for both experimental groups (P<0.004). Serium iPTH was significantly higher over the study period for both groups administered calcitonin. Serum BGP levels were significantly lower than controls during the study in group C (P<0.002) and to a lesser extent in group B (P<0.05). In group C, bone histomorphometry revealed increased resorption (onteoclast count), decreased trabecular bone volume, and decreased double-labeled tetracycline surface (bone formation). In group B an increase in osteoclast count but no alteration in bone formation was observed. To assess the role of PTH in the above findings, high-dose calcitonin was administered to parathyroidectomized rats. All of the above changes in bone histomorphometry were not observed in this group of animals. In conclusion, high doses of calcitonin promote hypocalcemia, secondary hyperparathyroidism, and osteoclastosis in the normal rat in a dose-dependent manner with very high-dose calcitonin impairing bone formation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Meunier PJ, Coindre JM, Edouard CM, Arlot ME (1980) Bone histomorphometry in Paget's disease: quantitative and dynamic analysis of pagetic and nonpagetic bone tissue. Arthr Rheum 23:1095
Greenberg PB, Doyle FH, Fisher MT, Hillyard CJ, Joplin GF, Pennock J, MacIntyre I (1974) Treatment of Paget's disease of bone with synthetic human calcitonin biochemical and roentgenologic changes. Am J Med 56:867
Galante L, Joplin GF, MacIntyre I, Woodhouse NJY (1973) The calcium-lowering effect of synthetic human, porcine and salmon calcitonin in patients with Paget's disease. Clin Science 44:605
Ziegler R, Holz G, Rave F, Minne H, Delling G (1977) Therapeutic studies with human calcitonin. In: MacIntyre I (ed) Human calcitonin and Paget's disease, 167 H Huber, Bern, Switzerland
Friedman J, Raisz LG (1965) Thyrocalcitonin: inhibitor of bone resorption in tissue culture. Science 150:1465
Ziegler R, Deutschle U, Raue F (1984) Calcitonin in human pathophysiology. Hormone Res 20:65
Delling GR, Schulz A, Ziegler R (1977) Changes of bone remodeling surfaces as bone structure in Paget's disease following long-term treatment with calcitonin. Calcif Tissue Res 22 (suppl):359
Hurley DL, Tiegs DR, Wahner HW, Heath H (1987) Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin. N Engl J Med 317:537
Chambers TJ, Magnus CJ (1982) Calcitonin alters behavior of isolated osteoclasts. J Pathol 136:27
Holtrop ME, Raisz LG, Simmons HA (1974) The effects of parathyroid hormone, colchicine and calcitonin on the ultrastructure and the activity of osteoclasts in organ culture. J Cell Biol 60:346
Baron R, Vignery A (1981) Behavior of osteoclasts during a rapid change in their number induced by high doses of parathyroid hormone or calcitonin in intact rats. Metab Bone Dis Rel Res 2:339–346
Ekeland A, Underdal T (1983) Effects of salmon calcitonin on systhesis and mineralization of collagen in rats. Acta Orthop Scand 54:470–478
Price PA, Lothringer JW, Nishimoto SK (1980) Absence of the vitamin K-dependent bone protein in fetal rat mineral. Evidence for another gamma-carboxyglutamic acidcontaining component in bone. J Biol Chem 255:2938
Jowell P, Epstein S, Fallon MD, Ismail F (1987) 1,25 Dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum BGP and bone histomorphometry. Endocrinology 120:531
Toverud SU, Boass A, Gardner SC, Endres DB (1986) Circulating parathyroid hormone concentrations in normal and vitamin D-deprived rap pups determined with an N-terminal specific radioimmunoassay. Bone and Mineral 1:145–155
Deftos LJ, First BP (1981) Calcitonin as a drug. Ann Int Med 95:192
Hedlund T, Hulth A, Johnell O (1983) Early effects of parathormone and calcitonin on the number of osteoclasts and on serum calcium in rats. Acta Orthop Scand 54:802
Gennari C, Chierichetti SM, Bigazzi S, Fusi S (1985) Comparative effects on bone mineral content of calcium and calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis. Curr Ther Res 38:455–464
Freed WJ, Perlow MJ, Wyatt RJ (1979) Calcitonin: inhibitory effect on eating in rats. Science 206:850
Shires R, Avioli LV, Bergfeld MA, Fallon MD, Slotopolsky E, Teitelbaum SL (1980) Effects of semi-starvation on skeletal homeostasis. Endocrinology 107:1530
Price PA, Parthemore JG, Deftos LJ (1980) New biochemical marker for bone metabolism: measurement by radioimmunoassay of BGP in the plasma of normal subjects and patients with bone disease. J Clin Invest 66:818
Slovitz DM, Gundberg CM, Neer RM, Lian JB (1984) Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. J Clin Endocrinol Metab 59:228
Ismail F, Epstein S, Fallon MD, Thomas SB, Reinhardt TA (1988) Serum bone gla protein and the vitamin D endocrine system in the oophorectomized rat. Endocrinology 122:624–630
Gundberg CM, Cole DEC (1985) Changes in serum osteocalcin associated with parathyroid hormone infusion in X-linked hypophosphosphatemic rickets. Clin Chem Acta 151:1
Calvo SM, Fryer MJ, Laakso JK, Nissenson RA, Price PA, Murray TM, Heath H (1985) Structural requirements for parathyroid hormone action in mature bone. J Clin Invest 76:2348
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Glajchen, N., Thomas, S., Jowell, P. et al. The effect of high-dose salmon calcitonin on bone mineral metabolism in the normal rat. Calcif Tissue Int 46, 28–32 (1990). https://doi.org/10.1007/BF02555821
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02555821